Benos D J, Watthey J W
J Pharmacol Exp Ther. 1981 Nov;219(2):481-8.
The inhibition and stimulation of short-circuit current in in vitro frog skin by a series of structural analogs of the diuretic drug amiloride were studied. Also, the inhibitory profile of a new experimental diuretic, 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine, or CGS 4270, was determined. The major conclusions of our studies are: 1) amiloride remains the most effective inhibitor of Na+ entry, with both the pyrazine ring and the acylguanidine moiety being required for maximum activity; 2) CGS 4270 also inhibits Na+ transport in frog skin; it acts only from the external solution, is uncharged, is noncompetitive with Na+ and interacts noncompetitively with amiloride; the inhibition is independent of external calcium; and 3) benzimidazole increases amiloride-sensitive short-circuit current and this compound is competitive with amiloride. These results indicate that the putative Na+ entry protein contains multiple inhibitory sites and that compounds which stimulate Na+ entry may also bind at the same molecular locus as an inhibitor.
研究了利尿药氨氯地平的一系列结构类似物对体外蛙皮短路电流的抑制和刺激作用。此外,还确定了一种新型实验性利尿药3-(3-氨基-1,2,4-恶二唑-5-基)-5-氯-2,6-吡嗪二胺(即CGS 4270)的抑制特性。我们研究的主要结论如下:1)氨氯地平仍然是最有效的Na⁺内流抑制剂,吡嗪环和酰基胍部分对于最大活性都是必需的;2)CGS 4270也抑制蛙皮中的Na⁺转运;它仅从外部溶液起作用,呈电中性,与Na⁺无竞争性,且与氨氯地平无竞争性相互作用;抑制作用与外部钙无关;3)苯并咪唑增加氨氯地平敏感的短路电流,且该化合物与氨氯地平具有竞争性。这些结果表明,假定的Na⁺内流蛋白含有多个抑制位点,并且刺激Na⁺内流的化合物可能也在与抑制剂相同的分子位点结合。